Pyrotinib is a pharmaceutical raw material and a HER2 inhibitor under clinical investigation for its potential role in cancer research. It is a synthetic compound with a complex aromatic and heterocyclic structure, including amide, amine, ether, and nitrile functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1269662-73-8
Shr-1258 dimaleate
pharmaceutical raw material
Neratinib
pharmaceutical raw material
Neratinib maleate
pharmaceutical raw material
Hydroxycarbamide
pharmaceutical raw material
Sulfacetamide sodium
pharmaceutical raw material
Sulfamerazine sodium
pharmaceutical raw material
Sulfabenzamide
pharmaceutical raw material
(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide
SADXACCFNXBCFY-IYNHSRRRSA-N
CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/[C@H]5CCCN5C